Dr Reddy's recalls over half a million Famotidine tablet bottles in US

Dr Reddy's Laboratories Limited has initiated a nationwide recall of over half a million bottles of Famotidine tablets, 10 mg, in the US after the drug failed impurities/degradation specifications in routine stability testing, according to the US Food and Drug Administration (US FDA).

Famotidine tablets are an over-the-counter product used to treat and prevent ulcers in the stomach and intestines. The company initiated the voluntary recall, which is still underway, of the product in multiple lots on October 3. 

The action was classified as a Class-III recall, meaning the products being recalled are unlikely to cause any adverse health reaction but violate